Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinsons disease
Perkovic V, Toto R, Cooper ME et al (2020) Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial
finished GLP-1 supplement products as complete formulas have not been clinically studied in the way prescription medications have been tested
These drugs mimic the physiological effects of GLP-1 by binding to GLP-1R, which enhances insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces food intake (Drucker, 2018)
This data-driven approach can support a more informed conversation with your provider about whether your current dosing frequency is optimal or whether adjustments might improve efficacy and consistency
the 1st Phorm App can help you achieve the results you've always wanted